References
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3d ed, rev. Washington, DC: Am Psychiatric Assn, 1987
- Rasmussen SA, Eisen JL. Epidemiology of obsessive compulsive disorder. J Clin Psychiatry 1990; 51(8 Suppl): 20–3
- Murphy DL, Pigott TA. Obsessive-compulsive disorder and its treatment with serotonin-selective agents. In: Meldrum BS, Williams M, eds. Current and future trends of anticonvulsants in anxiety and stroke therapy. New York: Wiley-Liss, 1990; 179–201
- Rachman S. Primary obsessional slowness. Behav Res Ther 1974; 12(1): 9–18
- The Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1991; 48(8): 730–8
- Mavissakalian M, Turner SM, Michelson L, et al. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II. Am J Psychiatry 1985; 142(5): 572–6
- Goodman WK, McDougle CJ, Price LH. Pharmacotherapy of obsessive compulsive disorder. J Clin Psychiatry 1992; 53(4 Suppl): 29–37
- Zohar J, Insel TR. Drug treatment of obsessive-compulsive disorder. J Affect Disord 1987; 13(2): 193–202
- Pato MT, Zohar-Kadouch R, Zohar J, et al. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am J Psychiatry 1988; 145(12): 1521–5
- Pigott TA, Pato MT, Bernstein SE, et al. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: behavioral and biological results. Arch Gen Psychiatry 1990; 47(10): 926–32
- Jenike MA Buttolph L, Baer L, et al. Open trial of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry 1989; 146(7): 909–11
- Chouinard G, Goodman W, Greist J, et al. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull 1990; 26(3): 279–84
- Heym J, Koe BK. Pharmacology of sertraline: a review. J Clin Psychiatry 1988; 49 (8 Suppl): 40–5
- Guthrie SK. Sertraline: a new specific serotonin reuptake blocker. DICP 1991; 25(9): 952–61
- Hollander E, DeCaria CM, Schneier FR, et al. Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment. J Clin Psychiatry 1990; 51(3): 119–23
- Marks IM, Hodgson R, Rachman S. Treatment of chronic obsessive-compulsive neurosis by in-vivo exposure: a two-year follow-up and issues in treatment. Br J Psychiatry 1975; 127: 349–64
- Minichiello WE, Baer L, Jenike MA. Behavior therapy for the treatment of obsessive-compulsive disorder: theory and practice. Compr Psychiatry 1988; 29(2): 123–37